ConductScience.org, home

Comparison · NCT03035201-62978d02

Cocoa Extract vs Cocoa Extract Placebo: Incident Mild Cognitive Impairment

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Cocoa Extract vs Cocoa Extract Placebo: Incident Mild Cognitive Impairment. Trial comparisons, record NCT03035201-62978d02. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03035201-62978d02

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.05130.03880.0676wilson
Risk in group 20.0670.05270.0848wilson
Risk difference, group 1 minus group 2-0.0157-0.03750.00593newcombe hybrid score
Risk ratio, group 1 over group 20.7660.5311.1log
Odds ratio, group 1 over group 20.7530.511.11log
Number needed to treat, for one fewer participant with the outcome on Cocoa Extract than on Cocoa Extract Placebo63.6from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: placebo.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Cocoa ExtractDaily cocoa extract (capsule containing 750 mg/d flavanols, including 75 mg (-)-epicatechin, and 90 mg theobromine)47916OG000
Group 2Cocoa Extract PlaceboDaily cocoa extract placebo63940OG001

Outcome

Type
SECONDARY
Title
Incident Mild Cognitive Impairment
Description
Mild cognitive impairment based on centralized adjudication of cognitive test scores and input from a proxy. Limited to participants free of mild cognitive impairment at baseline. Incidence over 3 years of follow-up.
Time frame
From baseline through year 3
Population
Limited to participants free of mild cognitive impairment at baseline. In a factorial design such as this, primary comparisons are cocoa flavanol vs cocoa flavanol placebo (pooling across multivitamin and multivitamin placebo) and multivitamin vs multivitamin placebo (pooling across cocoa flavanol and cocoa flavanol placebo). To provide outcomes for the four cells does not conform with the protocol or the published results and will not be consistent with the statistical analysis plan.

Source ClinicalTrials.gov

Trial

Title
COcoa Supplement and Multivitamin Outcomes Study for the Mind
NCT number
NCT03035201
Phases
Conditions
Cognitive Impairment, Dementia, Aging
Interventions
Lead sponsor
Wake Forest University Health Sciences
Results first posted
2023-08-22

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03035201-62978d02